首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Journal Of Immunotherapy

Journal Of Immunotherapy杂志,由Lippincott Williams and Wilkins Ltd.出版,于1997年创刊,Monthly,出版语言English,ISSN:1524-9557,E-ISSN:1537-4513。

投稿咨询
Journal Of Immunotherapy
Journal Of Immunotherapy
Journal Of Immunotherapy
SCI SCIE

杂志介绍

JCR分区
Q3
中科院分区
3区
影响因子
2.9
CiteScore
5.4
期刊收录
SCI、SCIE

Journal Of Immunotherapy(中文译名:《免疫疗法杂志》),ISSN:1524-9557,EISSN:1537-4513,是Lippincott Williams and Wilkins Ltd.出版的国际性学术期刊,创刊于1997年,以Monthly形式稳定发行,2026年总发文量约39篇。该刊采用非OA开放访问,学科归属为医学 - 免疫学。该刊是医学、肿瘤学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达2.9,2025年期刊CiteScore为5.4,2025年期刊自引率约0%,在中科院期刊分区体系中位列医学大类3区,在所属学科领域具备高学术影响力与国际认可度。Journal Of Immunotherapy长期聚焦医学、肿瘤学及相关产业的技术应用前沿,平均审稿周期较慢,6-12周,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、肿瘤学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,USACHINA MAINLAND、GERMANY (FED REP GER)、Italy、England、Canada、Japan等为核心发文国家与地区;SUN YAT SEN UNIVERSITYUNIVERSITY OF TEXAS SYSTEM、H LEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE、PEKING UNIVERSITY、RADBOUD UNIVERSITY NIJMEGEN、ARMY MEDICAL UNIVERSITY、GEORGETOWN UNIVERSITY等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
ONCOLOGY 肿瘤学 IMMUNOLOGY 免疫学 MEDICINE, RESEARCH & EXPERIMENTAL 医学:研究与实验
3区 3区 3区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
IMMUNOLOGY 免疫学 MEDICINE, RESEARCH & EXPERIMENTAL 医学:研究与实验 ONCOLOGY 肿瘤学
4区 4区 4区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
IMMUNOLOGY 免疫学 MEDICINE, RESEARCH & EXPERIMENTAL 医学:研究与实验 ONCOLOGY 肿瘤学
4区 4区 4区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:IMMUNOLOGY SCIE Q3 116 / 183

36.9

学科:MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q3 100 / 191

47.9

学科:ONCOLOGY SCIE Q3 175 / 333

47.6

学科:IMMUNOLOGY SCIE Q3 93 / 183

49.45

学科:MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q2 84 / 191

56.28

学科:ONCOLOGY SCIE Q2 151 / 333

54.8

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:IMMUNOLOGY SCIE Q3 99 / 183

46.2

学科:MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q2 93 / 195

52.6

学科:ONCOLOGY SCIE Q2 153 / 328

53.5

学科:IMMUNOLOGY SCIE Q3 92 / 183

50

学科:MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q2 92 / 195

53.08

学科:ONCOLOGY SCIE Q2 157 / 328

52.29


中国学者近期发文

1
Identification of Molecular Subtypes and a Novel Prognostic Model for Lung Squamous Cell Carcinoma Based on Adenylate Uridylate (AU)-Rich Element Gene

Author:Huang, Junchao; Chen, Siyang; Liu, Yakun

Journal: JOURNAL OF IMMUNOTHERAPY. 2026; Vol. 49, Issue 4, pp. 137-151. DOI: 10.1097/CJI.0000000000000580

2
Immune Checkpoint Inhibitor-Induced Ureteritis and Cystitis in Patients With Lung Cancer and Uterine Malignancies: A Case Series and Literature Revie

Author:Yan, Yu; Dou, Qiqi; Wu, Xuefei; Zhang, Xiaotong; Liu, Xiaoyan; Si, Xiaoyan; Zhang, Li

Journal: JOURNAL OF IMMUNOTHERAPY. 2026; Vol. 49, Issue 3, pp. 108-114. DOI: 10.1097/CJI.0000000000000581

3
Clinical Features, Treatment, and Prognosis of Pembrolizumab-Induced Isolated Adrenocorticotropic Hormone Deficienc

Author:Peng, Liping; Shu, Ming; Fan, Zhiqiang; Huang, Bin; Wang, Chunjiang

Journal: JOURNAL OF IMMUNOTHERAPY. 2026; Vol. 49, Issue 3, pp. 115-119. DOI: 10.1097/CJI.0000000000000584

4
Integrating Bulk RNA-Seq and Spatial Transcriptomics Data to Reveal Distinct Immune Escape Mechanism and Immunotherapy Based on Post-Translational Modification in Head and Neck Squamous Cell Carcinom

Author:Li, Kai; Cai, Chuyi; Chen, Qingmei; Hu, Danhua

Journal: JOURNAL OF IMMUNOTHERAPY. 2026; Vol. 49, Issue 3, pp. 120-134. DOI: 10.1097/CJI.0000000000000588

5
FGL1 as an Immune Checkpoint in the Immune Microenvironment of Bladder Cance

Author:Hu, Keyao; Ma, Xiaocheng; Luo, Lei; Li, Peng

Journal: JOURNAL OF IMMUNOTHERAPY. 2026; Vol. 49, Issue 3, pp. 98-107. DOI: 10.1097/CJI.0000000000000595

6
Design of Therapeutic Vaccines Based on Antigen Epitopes of α-9 HPV E6 in Sichua

Author:He, Jiaoyu; Cheng, Chunlan; Ding, Yishan; Li, Ning; Li, Tianjun; Wang, Chengyue; Wei, Bo; Ding, Xianping

Journal: JOURNAL OF IMMUNOTHERAPY. 2026; Vol. 49, Issue 3, pp. 87-97. DOI: 10.1097/CJI.0000000000000591

7
Comparing the Efficacy and Safety of IC-ICCRT-IO With CT-CCRT for Unresectable Locally Advanced ESCC: A Retrospective Analysi

Author:Wang, Ruifeng; Guo, Tianhui; Wang, Qi; Gao, Wen; Yu, Yimiao; Zhang, Jun; Fu, Wenqian; Zhang, Biyuan; Wang, Haiji

Journal: JOURNAL OF IMMUNOTHERAPY. 2026; Vol. 49, Issue 2, pp. 74-84. DOI: 10.1097/CJI.0000000000000578

8
Prognostic Role of Early Dynamic Changes in Neutrophil-to-Lymphocyte Ratio of Nonsmall Cell Lung Cancer Patient

Author:Liu, Xiaoyan; Zhang, Dongming; Zhang, Haoran; Shi, Yuequan; Liu, Jia; Gao, Xiaoxing; Chen, Minjiang; Zhao, Jing; Zhong, Wei; Xu, Yan; Wang, Mengzhao

Journal: JOURNAL OF IMMUNOTHERAPY. 2026; Vol. 49, Issue 2, pp. 64-73. DOI: 10.1097/CJI.0000000000000590

9
Integrative Multi-Omics Analysis Reveals Molecular Subtypes of Ovarian Cancer and Constructs Prognostic Model

Author:Zhou, Min; Pi, Jie; Zhao, Yuzi

Journal: JOURNAL OF IMMUNOTHERAPY. 2025; Vol. 48, Issue 6, pp. 197-208. DOI: 10.1097/CJI.0000000000000557

10
Identification of Immune Characteristics of 2 Subtypes of Breast Cancer by Combining Polyamine Metabolism-related Genes to Help With Immunotherap

Author:Yi, Xiuwen; Tang, Bin; Mo, Qinghua; Tang, Yulan; Fu, Wei; Zhang, Lingling; Xie, Liming

Journal: JOURNAL OF IMMUNOTHERAPY. 2025; Vol. 48, Issue 6, pp. 209-220. DOI: 10.1097/CJI.0000000000000559


在线咨询

Journal Of Immunotherapy

国际简称:J IMMUNOTHER参考译名:免疫疗法杂志

年发文量:39 CiteScore:5.4 是否预警:否 Gold OA文章占比:25.38% 研究类文章占比:100.00%

杂志社联系方式:LIPPINCOTT WILLIAMS & WILKINS, 530 WALNUT ST, PHILADELPHIA, USA, PA, 19106-3621

Journal Of Immunotherapy